OraSure patent settlement
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies will pay $3 million to Inverness to settle a patent infringement lawsuit, the firm announces Nov. 19. The settlement grants OraSure non-exclusive licenses to lateral flow technology patents for the OraQuick HIV-1/2 test and HCV test. In addition, each party has received distribution rights to certain products supplied by the other party, for certain markets, according to OraSure
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.